Presentation THT 2023 Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Updated Results of the REBALANCE-HF Trial Roll-in Cohort Presenter: Marat Fudim March 21, 2023
Presentation THT 2023 Right Heart Failure with Preserved Ejection Fraction: A New Clinical Phenotype with Clinical and Prognostic Relevance Presenter: Athiththan Yogeswaran March 20, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
Presentation ACC 2023 Rate-Adaptive Atrial Pacing for Heart Failure with preserved Ejection Fraction: The RAPID-HF trial Presenter: Barry A. Borlaug March 06, 2023
News Conference News ACC 2023 RAPID-HF: Rate-Adaptive Pacing Doesn’t Help in HFpEF Todd Neale March 05, 2023
News Daily News Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression L.A. McKeown February 17, 2023
News Daily News Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs Todd Neale January 23, 2023
News Daily News HF Specialists Detail ‘Road Map’ for Improving HF Training Pipeline Shelley Wood January 04, 2023
News Daily News Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS Michael O'Riordan December 30, 2022
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Industry News Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial December 06, 2022
News Conference News AHA 2022 IRONMAN Misses but Lends Support to IV Iron Repletion in HF Shelley Wood November 05, 2022
News Conference News HFSA 2022 New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented Todd Neale October 07, 2022
News Conference News HFSA 2022 Dapagliflozin’s Benefits Similar in HF Patients With Improved EF: DELIVER Todd Neale October 04, 2022